143 related articles for article (PubMed ID: 9800150)
1. The treatment of severe forms of myasthenia gravis.
Iani C; Caramia M; Morosetti M; Loberti M; Palmieri MG; Meloni C; Gallucci MT; Casciani CU; Bernardi G
Funct Neurol; 1998; 13(3):231-7. PubMed ID: 9800150
[TBL] [Abstract][Full Text] [Related]
2. Plasmapheresis in severe forms of myasthenia gravis.
Morosetti M; Meloni C; Iani C; Caramia M; Galderisi C; Palombo G; Gallucci MT; Bernardi G; Casciani CU
Artif Organs; 1998 Feb; 22(2):129-34. PubMed ID: 9491902
[TBL] [Abstract][Full Text] [Related]
3. [Favorable results of plasmapheresis in severe myasthenia gravis].
Blom RJ; Kuks JB; Westerterp-Maas A; Oosterhuis HJ
Ned Tijdschr Geneeskd; 1997 Feb; 141(8):381-4. PubMed ID: 9157298
[TBL] [Abstract][Full Text] [Related]
4. A randomized and controlled study comparing immunoadsorption and plasma exchange in myasthenic crisis.
Köhler W; Bucka C; Klingel R
J Clin Apher; 2011 Dec; 26(6):347-55. PubMed ID: 22095647
[TBL] [Abstract][Full Text] [Related]
5. Clinical predictors of steroid-induced exacerbation in myasthenia gravis.
Bae JS; Go SM; Kim BJ
J Clin Neurosci; 2006 Dec; 13(10):1006-10. PubMed ID: 17074487
[TBL] [Abstract][Full Text] [Related]
6. Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Myasthenia Gravis Clinical Study Group.
Gajdos P; Chevret S; Clair B; Tranchant C; Chastang C
Ann Neurol; 1997 Jun; 41(6):789-96. PubMed ID: 9189040
[TBL] [Abstract][Full Text] [Related]
7. Periodic therapeutic plasma exchange in patients with moderate to severe chronic myasthenia gravis non-responsive to immunosuppressive agents: an eight year follow-up.
Triantafyllou NI; Grapsa EI; Kararizou E; Psimenou E; Lagguranis A; Dimopoulos A
Ther Apher Dial; 2009 Jun; 13(3):174-8. PubMed ID: 19527462
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of myasthenia gravis with plasmapheresis (author's transl)].
Reuther P; Wiebecke D; Hertel G; Böske A; Mertens HG
Dtsch Med Wochenschr; 1979 Dec; 104(51):1806-10. PubMed ID: 520174
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic plasma exchange in patients with neurologic diseases: retrospective multicenter study.
Kaynar L; Altuntas F; Aydogdu I; Turgut B; Kocyigit I; Hacioglu SK; Ismailogullari S; Turgut N; Erkurt MA; Sari I; Oztekin M; Solmaz M; Eser B; Ersoy AO; Unal A; Cetin M
Transfus Apher Sci; 2008 Apr; 38(2):109-15. PubMed ID: 18331814
[TBL] [Abstract][Full Text] [Related]
10. [Association of plasmapheresis and high doses of intravenous immunoglobulins in the treatment of myasthenia gravis].
Tatay J; Díez-Tejedor E; Frank A; Tejada J; Marrero C; Barreiro P
Rev Neurol; 1997 Sep; 25(145):1402-6. PubMed ID: 9377299
[TBL] [Abstract][Full Text] [Related]
11. Post-thymectomy combined treatment of prednisone and tacrolimus versus prednisone alone for consolidation of complete stable remission in patients with myasthenia gravis: a non-randomized, non-controlled study.
Ponseti JM; Gamez J; Azem J; Fort JM; López-Cano M; Vilallonga R; Buera M; Armengol M
Curr Med Res Opin; 2007 Jun; 23(6):1269-78. PubMed ID: 17559724
[TBL] [Abstract][Full Text] [Related]
12. Long-term treatment of myasthenia gravis with immunoadsorption.
Haas M; Mayr N; Zeitlhofer J; Goldammer A; Derfler K
J Clin Apher; 2002; 17(2):84-7. PubMed ID: 12210711
[TBL] [Abstract][Full Text] [Related]
13. [Clinical study of double filtration plasmapheresis for treatment of refractory myasthenia gravis].
Huo JT; Long HL; Luo X; Xu JZ
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):355-7. PubMed ID: 17425991
[TBL] [Abstract][Full Text] [Related]
14. [Corticosteroids in the treatment of myasthenia gravis. Study of 12 cases with review of the literature].
Lamartine de Assis J
Arq Neuropsiquiatr; 1975 Mar; 33(1):33-40. PubMed ID: 1164206
[TBL] [Abstract][Full Text] [Related]
15. Plasmapheresis does not affect polysomnographic parameters in patients with myasthenia gravis: a case series study.
Yeh JH; Chen WH; Chiu HC; Lee CT; Hsu CY
Artif Organs; 2010 Jun; 34(6):E200-3. PubMed ID: 20456321
[TBL] [Abstract][Full Text] [Related]
16. Plasmapheresis therapy in myasthenia gravis.
Dau PC
Muscle Nerve; 1980; 3(6):468-82. PubMed ID: 7453714
[TBL] [Abstract][Full Text] [Related]
17. Prethymectomy plasmapheresis in myasthenia gravis.
Yeh JH; Chen WH; Huang KM; Chiu HC
J Clin Apher; 2005 Dec; 20(4):217-21. PubMed ID: 16035101
[TBL] [Abstract][Full Text] [Related]
18. [Plasmapheresis in patients with myasthenia gravis].
Konishi T
Nihon Rinsho; 2008 Jun; 66(6):1165-71. PubMed ID: 18540364
[TBL] [Abstract][Full Text] [Related]
19. [A comparative study of intravenous immunoglobulin and plasmapheresis preoperatively in myasthenia].
Pérez Nellar J; Domínguez AM; Llorens-Figueroa JA; Ferrá-Betancourt A; Pardo A; Quiala M; Gali Z
Rev Neurol; 2001 Sep 1-15; 33(5):413-6. PubMed ID: 11727205
[TBL] [Abstract][Full Text] [Related]
20. Clinical remission following plasmapheresis and corticosteroid treatment in a dog with acquired myasthenia gravis.
Bartges JW; Klausner JS; Bostwick EF; Hakala JE; Lennon VA
J Am Vet Med Assoc; 1990 Apr; 196(8):1276-8. PubMed ID: 2332375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
